Tweets
Excellent pragmatic RCT, TNF withdrawal in RA
Almost 2/3 flared by 1 yr; at 3 years up to 3 in 4
Supports my practice of generally continuing TNFs long term
Also highlights importance of pt preferences; 1 in 4 may do well if they wish to discontinue
@RheumNow #ACR23 #ACRBest https://t.co/G4l0DgBP2Z
Mike Putman @EBRheum ( View Tweet )
2 years 3 months ago
Vaccination appears to be effective and safe post CAR-T treatment. This sets the stage for better understanding of the patient experience. Dr. Schett #ACR23 @RheumNow https://t.co/OQCNTt5wPh
Dr. Rachel Tate ( View Tweet )
2 years 3 months ago
In case you missed it! Watch our ACR Monday Recap of the meeting with me, @RheumNow @EBRheum and @ericdeinmd. #ACR23 @uptoTate https://t.co/GpMdev0Yk7
TheDaoIndex @KDAO2011 ( View Tweet )
2 years 3 months ago
#ACR23 Abs #2548 showed incidence rate of uveitis TEAEs was lower to Wk 16 in axSpA pts randomized to BKZ 160 mg Q4W vs PBO. https://t.co/kBLQnJbTU2 @rheumnow https://t.co/regYgvvCts
Dr. Rachel Tate ( View Tweet )
2 years 3 months ago
Bimekizumab is Coming… in 3rd Place
Nearly two dozen bimekizumab abstracts will be featured at #ACR23 and it recently received authorization in Europe and the US for psoriasis.
https://t.co/i2ptDnGr4a https://t.co/rZC6IORm5E
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
#ACR23 Daily Recap - MONDAY
Join our live-stream panel discussion as we dive deep into the highlights and key takeaways from day two of ACR 2023. https://t.co/0WXuV3wzzF
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
ACR2023 Daily Recap - MONDAY
Join our live-stream panel discussion as we dive deep into the highlights and key takeaways from day two of ACR 2023. https://t.co/qOjSd8vuB3
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Join us tonight at 6pm PT/ 9pm ET for our daily #ACR23 recap. https://t.co/jjcnekqVPe
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Early experience w/SGLT2i in SLE (Prof Petri):
👉Reduction of decline in eGFR after SGLT2i
👉Improvement in RUPCR after SGLT2i
BUT observed differences not significant when compared w/prior to starting SGLT2i
Small sample size. Longer ffup needed.
#ACR23 ABST1490 @RheumNow https://t.co/IhVFacRi0g
sheila ( View Tweet )
2 years 3 months ago
Went into more depth on this great topic of IBD in SpA on @RheumNow #ACR23
Should we be screening SpA patients with fecal calprotectin to look for undiagnosed SpA?
https://t.co/TmXhm2MEfO https://t.co/SWJSqF5pkW
Eric Dein ( View Tweet )
2 years 3 months ago
You said that CAR-T needs a #RCT in severe #SLE @RheumNow @ACRheum #ACR23 https://t.co/yilohqz1YE
Janet Pope ( View Tweet )
2 years 3 months ago
